WASHINGTON DC: A study released on Thursday, December 3, showed that the Moderna COVID-19 vaccine can produce potent antibodies in the human immune system which will endure for at least three months. The vaccine, co-developed by researchers at National Institute for Allergies and Infectious Diseases (NIAID), was recently tested to be almost 94 per cent effective. They studied the immune response of 34 adult participants (young and old), from the first stage of clinical trials.
The report, published in the New England Journal of Medicine, said that antibodies which inhibit the SARS-CoV-2 from invading the human cells declined slowly with time as expected. However, the antibodies remained for a period of 3 months in all the participants after the booster vaccination. The vaccine, known as mRNA-1273, is given in two doses within a period of 28 days.
Anthony Fauci, Director, NIAID, said that there are good chances that the immune system will remember the novel coronavirus and will produce new antibodies to protect the body. The study showed that the vaccine activated a certain type of immune cell which should help in memory response.
Representative Image NEW DELHI: The India Meteorological Department (IMD) has issued a warning regarding an…
Representative Image JAMMU and KASHMIR: The National Green Tribunal (NGT) has called upon the Central…
Representative Image NEW DELHI: The 19th edition of the United Nations Forum on Forests (UNFF…
Representative Image MUMBAI, Maharashtra: The Brihanmumbai Municipal Corporation (BMC) has published a list of 188…
Representative Image CHENNAI, Tamil Nadu: The Greater Chennai Municipal Corporation is mulling the plan to…
Representative Image TRICHIRAPALLI, Tamil Nadu: Faulty Streetlights on the newly built Kollidam Bridge in Trichy…